These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 29131714)

  • 1. Understanding variations in secondary findings reporting practices across U.S. genome sequencing laboratories.
    Ackerman SL; Koenig BA
    AJOB Empir Bioeth; 2018; 9(1):48-57. PubMed ID: 29131714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.
    Smith LA; Douglas J; Braxton AA; Kramer K
    J Genet Couns; 2015 Aug; 24(4):654-62. PubMed ID: 25403901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misattributed parentage as an unanticipated finding during exome/genome sequencing: current clinical laboratory practices and an opportunity for standardization.
    Eno C; Bayrak-Toydemir P; Bean L; Braxton A; Chao EC; El-Khechen D; Esplin ED; Friedman B; Hagman KDF; Hambuch T; Hernandez A; Juusola J; Londre G; Machado J; Mao R; Mighion L; Rehm HL; Ward P; Deignan JL
    Genet Med; 2019 Apr; 21(4):861-866. PubMed ID: 30214068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).
    Ploug T; Holm S
    PLoS One; 2017; 12(7):e0179935. PubMed ID: 28671958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories.
    O'Daniel JM; McLaughlin HM; Amendola LM; Bale SJ; Berg JS; Bick D; Bowling KM; Chao EC; Chung WK; Conlin LK; Cooper GM; Das S; Deignan JL; Dorschner MO; Evans JP; Ghazani AA; Goddard KA; Gornick M; Farwell Hagman KD; Hambuch T; Hegde M; Hindorff LA; Holm IA; Jarvik GP; Knight Johnson A; Mighion L; Morra M; Plon SE; Punj S; Richards CS; Santani A; Shirts BH; Spinner NB; Tang S; Weck KE; Wolf SM; Yang Y; Rehm HL
    Genet Med; 2017 May; 19(5):575-582. PubMed ID: 27811861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting practices for variants of uncertain significance from next generation sequencing technologies.
    Vears DF; Sénécal K; Borry P
    Eur J Med Genet; 2017 Oct; 60(10):553-558. PubMed ID: 28774848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Return of non-ACMG recommended incidental genetic findings to pediatric patients: considerations and opportunities from experiences in genomic sequencing.
    Bowling KM; Thompson ML; Kelly MA; Scollon S; Slavotinek AM; Powell BC; Kirmse BM; Hendon LG; Brothers KB; Korf BR; Cooper GM; Greally JM; Hurst ACE
    Genome Med; 2022 Nov; 14(1):131. PubMed ID: 36414972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
    Kalia SS; Adelman K; Bale SJ; Chung WK; Eng C; Evans JP; Herman GE; Hufnagel SB; Klein TE; Korf BR; McKelvey KD; Ormond KE; Richards CS; Vlangos CN; Watson M; Martin CL; Miller DT
    Genet Med; 2017 Feb; 19(2):249-255. PubMed ID: 27854360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation among Consent Forms for Clinical Whole Exome Sequencing.
    Fowler SA; Saunders CJ; Hoffman MA
    J Genet Couns; 2018 Feb; 27(1):104-114. PubMed ID: 28689263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
    Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory policies on reporting secondary findings in clinical whole exome sequencing: initial uptake of the ACMG's recommendations.
    Hufnagel SB; Antommaria AH
    Am J Med Genet A; 2014 May; 164A(5):1328-31. PubMed ID: 24458369
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing the ethical challenges of next-generation sequencing in genomic medicine.
    Clarke AJ
    Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting practices for unsolicited and secondary findings from next-generation sequencing technologies: Perspectives of laboratory personnel.
    Vears DF; Sénécal K; Borry P
    Hum Mutat; 2017 Aug; 38(8):905-911. PubMed ID: 28512758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic counselors' views and experiences with the clinical integration of genome sequencing.
    Machini K; Douglas J; Braxton A; Tsipis J; Kramer K
    J Genet Couns; 2014 Aug; 23(4):496-505. PubMed ID: 24671342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
    Evans BJ
    Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
    Miller DT; Lee K; Abul-Husn NS; Amendola LM; Brothers K; Chung WK; Gollob MH; Gordon AS; Harrison SM; Hershberger RE; Klein TE; Richards CS; Stewart DR; Martin CL;
    Genet Med; 2023 Aug; 25(8):100866. PubMed ID: 37347242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethical issues in genome-era].
    Kosugi S
    Nihon Rinsho; 2016 Jun; 74(6):1022-7. PubMed ID: 27311196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
    Hart MR; Biesecker BB; Blout CL; Christensen KD; Amendola LM; Bergstrom KL; Biswas S; Bowling KM; Brothers KB; Conlin LK; Cooper GM; Dulik MC; East KM; Everett JN; Finnila CR; Ghazani AA; Gilmore MJ; Goddard KAB; Jarvik GP; Johnston JJ; Kauffman TL; Kelley WV; Krier JB; Lewis KL; McGuire AL; McMullen C; Ou J; Plon SE; Rehm HL; Richards CS; Romasko EJ; Miren Sagardia A; Spinner NB; Thompson ML; Turbitt E; Vassy JL; Wilfond BS; Veenstra DL; Berg JS; Green RC; Biesecker LG; Hindorff LA
    Genet Med; 2019 May; 21(5):1100-1110. PubMed ID: 30287922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.